| DNA methylation and dietary sodium intake |
Jeong Yun (John) Yang |
Columbia University Irving Medical Center |
PLCO |
Feb 17, 2026 |
PLCO-2023 |
| Dietary Advanced Glycation End-Products (dAGE) and Prostate Cancer |
Susan Steck |
University of South Carolina |
PLCO |
Feb 13, 2026 |
PLCO-2021 |
| Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods, and causal survival models |
Hansapani Rodrigo |
University of Texas Rio Grande Valley |
PLCO |
Feb 4, 2026 |
PLCO-2015 |
| Epstein-Barr virus-associated neo-antigens in advanced prostate cancer |
Denong Wang |
SRI International |
PLCO |
Feb 2, 2026 |
2025-0062 |
| Impact of a secondary biomarker on time-to-event risk prediction of prostate cancer mortality in a screening cohort |
Kristian Stensland |
The University of Michigan |
PLCO |
Jan 26, 2026 |
PLCO-2012 |
| Association between microplastic concentration in whole blood and risk of colorectal cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Rena Jones |
National Cancer Institute |
PLCO |
Jan 26, 2026 |
2025-0059 |
| Incidence Rates of Lung and Bladder Cancer According to Smoking Status and Tumor Subtype: An Analysis of Absolute Risk in Never Smokers |
Sarina Murray |
National Cancer Institute |
PLCO |
Jan 16, 2026 |
PLCO-2017 |
| Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods along and causal survival models |
Malinda Iluppangama |
Loyola University Maryland |
PLCO |
Jan 8, 2026 |
PLCO-2009 |
| Developing a risk calculator for the early detection of prostate cancer |
Visalini Nair-Shalliker |
The Daffodil Centre, The University Sydney, and Cancer Council,NSW |
PLCO |
Dec 22, 2025 |
PLCO-1993 |
| Learning about the effectiveness of lung cancer screening in real-world target populations |
Sarah Robertson |
Dartmouth College |
PLCO |
Dec 22, 2025 |
PLCO-2005 |
| Evaluating Multi-trait PRS Methods on Cancer Phenotypes in PLCO |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2004 |
| Developing Contextualized Cancer Risk Models: Integrating Polygenic Risk Scores with Environmental, Geospatial, and Social Determinants of Health Data |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2003 |
| Comparative Analysis of Military Veteran Cancer Biomarkers Using the PLCO Dataset as a Civilian Control Cohort |
Chelsey Simoni |
HunterSeven Foundation |
PLCO |
Dec 10, 2025 |
PLCO-1989 |
| Identifying Proteomics Associated with Diet |
Steven Moore |
National Cancer Institute |
PLCO |
Dec 1, 2025 |
PLCO-2001 |
| Geographical Variation in Estrogen Levels |
Steven Moore |
National Cancer Institute |
PLCO |
Dec 1, 2025 |
PLCO-1999 |
| Can we predict early biochemical response after chemotherapy in Stage IV colon cancer patients using baseline clinical and treatment features |
Dr. Johnson P. Thomas |
Oklahoma State University |
PLCO |
Nov 24, 2025 |
PLCO-1994 |
| Synthetic Clinical Trial based on Polygenic Risk Scores |
Mitchell Machiela |
National Cancer Institute |
PLCO |
Nov 24, 2025 |
PLCO-1998 |
| Building Digital Twin Framework for Personalization of Prostate Cancer Management in Kidney Transplant Patients |
Naoru Koizumi |
George Mason University |
PLCO |
Nov 17, 2025 |
PLCO-1997 |
| Competing risks analysis of multiple cancers with application to vitamin D in PLCO |
Yei Eun Shin |
Seoul National University |
PLCO |
Nov 17, 2025 |
PLCO-1979 |
| Phytoestrogen Intake and Risk of Endometrial Cancer |
Michael Reger |
University of Notre Dame |
PLCO |
Nov 13, 2025 |
PLCO-1996 |
